First MD Simulations of Full Structure HIV1/GP120 in Complex with CD4 and CCR5
7th International Bau Drug Design Congress: Recent Developments in Structure- and Ligand-based Drug Design Methodologies, İstanbul/TÜRKİYE, 19 Aralık 2022
DOĞAN BERNA, DURDAĞI SERDAR
|
De novo Antineoplastic Drug Design to Suppress Head, Neck and Oral Cancer using Theoretical Organic and Biochemistry via Comprehensive Molecular Docking and Dynamics
Asian Pacific Journal of Cancer Prevention, Vol. 25, No. 8, Ağustos 2024, s. 2905-2909, ISSN: 2476-762X
AĞAR SOYKAN,MOKHTARİ MOHADDESEH,YANIK MUHAMMED,AKKURT BARBAROS,ULUKAYA ENGİN,TERZİ RABİA
|
Searching New MAO-B Hit Inhibitors with Integrated Computational Drug Design Methods
6. BAU Drug Design Congress, İstanbul/TÜRKİYE, 13 Aralık 2018
İŞ YUSUF SERHAT,DURDAĞI SERDAR,AKSOYDAN BUSECAN,YURTSEVER MİNE
|
New Drug Candidates for Neurodegenerative Diseases Discovered by Virtual Screening Methods and Verified by in-vitro Studies
7 International BAU Drug Design Congress, 19 Aralık 2019
YURTSEVER MİNE
|
Quantum and Classical Approaches to Structure Dynamics and Interactions of human Dopamine D2 Receptor
4th International BAU Drug Design Congress, 13 Ekim 2016
YURTSEVER MİNE
|
On the Understanding of PDE Inhibitors-hERG K Ion Channel Interactions and Computational Design of Novel, Potent and Safe PDE5 Inhibitors
th International Bau Drug Design Congress, 19 Ekim 2017
KAYIK GÜLRU,TÜZÜN NURCAN,DURDAĞI SERDAR
|
A Molecular Docking Study on O-Acetylpeptidoglucan Esterase
5th International Bau Drug Design Congress, 19 Ekim 2017
TATAROĞLU MUAMMER MELİN,AKSAKAL ZEYNEP,TÜZÜN NURCAN,SUNGUR FETHİYE AYLİN
|
Clay mineral particles as imaging and drug delivery agents
6th International BAU Drug Design Congress, 13 Aralık 2018
BEKAROĞLU MAİDE GÖKÇE,NURİLİ FUAD,İŞÇİ TURUTOĞLU SEVİM
|
A Molecular Docking Study on O-Acetylpeptidoglucan Esterase
5th International Bau Drug Design Congress, 19 Ekim 2017
TATAROĞLU MUAMMER MELİN,AKSAKAL ZEYNEP,TÜZÜN NURCAN,SUNGUR FETHİYE AYLİN
|
Umbelliferone: a small and bioactive molecule
5th International Drug Design Congress, Bahcesehir University School of Medecine, Istanbul, Turkey, 19 Ekim 2017
ÖZDEMİR AYŞE,DARBUKA ELİF,GÜNAYDIN KERİMAN
|
Applications Of Molecular Modeling Approaches For The Identification Of Novel Sars-Cov-2 Rdrp Inhibitors
2. Computer-Aided Drug Design Symposium and Workshop - Linking Design, Biology, Chemistry and Medicine, İstanbul/TÜRKİYE, 11 Mayıs 2022
DOĞAN BERNA, DURDAĞI SERDAR, MOTAPANYANE, NTSOAKİ BAİTHEDİ
|
Quantitative prediction of compound selectivity against HDAC1 and HDAC6 isoforms
ordon Research Conference on Computer Aided Drug Design, Vermont/AMERİKA BİRLEŞİK DEVLETLERİ, 16 Temmuz 2023
DOĞAN BERNA
|
A new pollen derived microcarrier for Pantoprazole delivery
4th International Bahçeşehir University (BAU) Drug Design Congress, 13 Ekim 2016
AKYÜZ LALEHAN,SARGİN IDRİS,ÇETER TALİP,KAYA MURAT
|
In silico design of novel hERG-neutral sildenafil-like PDE5 inhibitors
JOURNAL OF BIOMOLECULAR STRUCTURE DYNAMICS, Vol. 35, No. 13, 2017, s. 2830-2852, ISSN: 0739-1102
KAYİK GULRU,TÜZÜN NURCAN,DURDAĞI SERDAR
|
Design and development of pva/hydrocortisone loaded xerogel nanofibrous mat for topical drug delivery
Lisansüstü Eğitim Enstitüsü, İstanbul Teknik Üniversitesi, 2023
HISHAM ALI MUHAMMAD ALI MOUSSA
|
Design of in silico new drug molecules for type 2 diabetes treatment
Fen Bilimleri Enstitüsü, Üsküdar Üniversitesi, 2022
ENES ZURNACI
|
Exploring allosteric mechanisms of chemokine receptor CXCR4 and implications in drug design
Lisansüstü Eğitim Enstitüsü, İstanbul Teknik Üniversitesi, 2023
TUĞÇE İNAN
|
Structure-based drug design studies for the discovery of novel carbonic anhydrase IX-selective inhibitors
Fen Bilimleri Enstitüsü, İstanbul Teknik Üniversitesi, 2019
VUSLAT ÖYKÜ SAYIN
|
Investigation of Role of Fluorine Atoms in the Activity of Well-Known Fluorine Containing Marketed Drugs: DFT and Docking Studies
7th International BAU Drug Design Congress, 19 Aralık 2019
AYDIN YILDIZ,İŞ YUSUF SERHAT,DURDAĞI SERDAR,YURTSEVER MİNE
|
Investigation of Role of Fluorine Atoms in the Activity of Well-Known Fluorine Containing Marketed Drugs: DFT and Docking Studies
7th International BAU Drug Design Congress, 19 Aralık 2019
AYDIN YILDIZ,İŞ YUSUF SERHAT,DURDAĞI SERDAR,YURTSEVER MİNE
|